CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
暂无分享,去创建一个
[1] A D Kelleher,et al. A model of primary HIV-1 infection. , 1998, Mathematical biosciences.
[2] C. Burrell,et al. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus. , 1992, The Journal of general virology.
[3] Hana Golding,et al. Coreceptor Competition for Association with CD4 May Change the Susceptibility of Human Cells to Infection with T-Tropic and Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[4] M. Greenberg,et al. Evolution of the Human Immunodeficiency Virus Type 1 Envelope during Infection Reveals Molecular Corollaries of Specificity for Coreceptor Utilization and AIDS Pathogenesis , 2000, Journal of Virology.
[5] Lisa M. Ebert,et al. Coregulation of CXC Chemokine Receptor and CD4 Expression on T Lymphocytes During Allogeneic Activation1 , 2001, The Journal of Immunology.
[6] M. Baggiolini,et al. Activation of blood T lymphocytes down‐regulates CXCR4 expression and interferes with propagation of X4 HIV strains , 1998, European Journal of Immunology.
[7] P. Secchiero,et al. Engagement of CD28 Modulates CXC Chemokine Receptor 4 Surface Expression in Both Resting and CD3-Stimulated CD4+ T Cells1 , 2000, The Journal of Immunology.
[8] J. McCune,et al. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. , 1998, Journal of immunology.
[9] Lorenz T. Biegler,et al. Targeting strategies for the synthesis and energy integration of nonisothermal reactor networks , 1992 .
[10] Benhur Lee,et al. Interferon-γ Upregulates CCR5 Expression in Cord and Adult Blood Mononuclear Phagocytes , 1999 .
[11] C. Mackay,et al. Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.
[12] A. McLean,et al. Modelling T cell memory. , 1994, Journal of theoretical biology.
[13] A A Ding,et al. Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics. , 1999, Mathematical biosciences.
[14] M. Ostrowski,et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. , 1998, Journal of immunology.
[15] D. Farber,et al. T cell memory: heterogeneity and mechanisms. , 2000, Clinical immunology.
[16] T. van der Poll,et al. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines. , 2000, Blood.
[17] K. Anastos,et al. Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. , 2001, The Journal of clinical investigation.
[18] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[19] A. Meyerhans,et al. Kinetics of CXCR4 and CCR5 up-regulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4(+) T lymphocytes. , 2000, Blood.
[20] R W Makuch,et al. A stochastic modeling of early HIV-1 population dynamics. , 2001, Mathematical biosciences.
[21] T. Chun,et al. Latent reservoirs of HIV: obstacles to the eradication of virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Abbas,et al. Cellular and Molecular Immunology , 1991 .
[23] Peng Li,et al. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. , 1999, Virology.
[24] J. Orenstein,et al. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1 , 1995, Journal of virology.
[25] J. Margolick,et al. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[26] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Ferrari,et al. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] H C Tuckwell,et al. A stochastic model for early HIV-1 population dynamics. , 1998, Journal of theoretical biology.
[29] J. Levy,et al. Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation , 1995, Journal of virology.
[30] M. Dybul,et al. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Ho,et al. Toward HIV eradication or remission: the tasks ahead. , 1998, Science.
[32] D. Littman,et al. Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Roth,et al. Costimulation of Naive CD8+ Lymphocytes Induces CD4 Expression and Allows Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[34] R. Rabin,et al. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.
[35] A S Perelson,et al. Modeling HIV infection of CD4+ T-cell subpopulations. , 1994, Journal of theoretical biology.
[36] Hanneke Schuitemaker,et al. Analysis of the Temporal Relationship between Human Immunodeficiency Virus Type 1 Quasispecies in Sequential Blood Samples and Various Organs Obtained at Autopsy , 1998, Journal of Virology.
[37] W Turner,et al. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. , 1998, The Journal of clinical investigation.
[38] J. Kahn,et al. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] D. Ho,et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission , 1996, Journal of virology.
[40] J. Tse,et al. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. , 1998, AIDS research and human retroviruses.
[41] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[42] E. De Clercq,et al. Role of CXCR4 in Cell-Cell Fusion and Infection of Monocyte-Derived Macrophages by Primary Human Immunodeficiency Virus Type 1 (HIV-1) Strains: Two Distinct Mechanisms of HIV-1 Dual Tropism , 1999, Journal of Virology.
[43] R. Doms,et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses , 1997, Journal of virology.
[44] R. Collman,et al. Heterogeneous Spectrum of Coreceptor Usage among Variants within a Dualtropic Human Immunodeficiency Virus Type 1 Primary-Isolate Quasispecies , 2000, Journal of Virology.
[45] R I Shrager,et al. HIV-1 infection kinetics in tissue cultures. , 1996, Mathematical biosciences.
[46] S. Hussain,et al. Heterogeneity of the Memory CD4 T Cell Response: Persisting Effectors and Resting Memory T Cells1 , 2001, The Journal of Immunology.
[47] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[48] R P Johnson,et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.
[49] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[50] D. Margolis,et al. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Weissman,et al. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[52] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[53] R. Doms,et al. Identification of Determinants on a Dualtropic Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Confer Usage of CXCR4 , 1998, Journal of Virology.
[54] P. Brennan,et al. Initiation of reverse transcription during cell-to-cell transmission of human immunodeficiency virus infection uses pre-existing reverse transcriptase. , 1994, The Journal of general virology.
[55] David Kendrick,et al. GAMS, a user's guide , 1988, SGNM.
[56] J. Harrison,et al. Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[57] M. McElrath,et al. Dendritic Cell–T-Cell Interactions Support Coreceptor-Independent Human Immunodeficiency Virus Type 1 Transmission in the Human Genital Tract , 1999, Journal of Virology.
[58] Y. Yan,et al. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. , 2000, International immunology.
[59] S. Worgall,et al. Expression and Use of Human Immunodeficiency Virus Type 1 Coreceptors by Human Alveolar Macrophages , 1999, Journal of Virology.
[60] E. De Clercq,et al. Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4 , 1999, Journal of Virology.
[61] A. Badley,et al. Mechanisms of HIV-associated lymphocyte apoptosis. , 2000, Blood.
[62] Hassan Mohammad Naif,et al. CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[63] M. Lenardo,et al. TNF-α-Induced Secretion of C-C Chemokines Modulates C-C Chemokine Receptor 5 Expression on Peripheral Blood Lymphocytes , 2000, The Journal of Immunology.
[64] Takayuki Itoh,et al. Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.
[65] J. Lalonde,et al. Polarized Human Immunodeficiency Virus Budding in Lymphocytes Involves a Tyrosine-Based Signal and Favors Cell-to-Cell Viral Transmission , 1999, Journal of Virology.